Clinical trial Recruiting at 2 sites Interventional Ages 3 Months to 12 Months

Early family-centered intervention for infants at high risk of cerebral palsy

Official title: Early Family-Centered Intervention for Infants With High-Risk of Cerebral Palsy: Protocol for the Randomized Controlled GO-PLAY Trial

Run by Copenhagen University Hospital, Rigshospitalet · NCT05883969 · Data updated 2026-11-12

This study is testing a new program called GO-PLAY to see if it can help infants at high risk for cerebral palsy develop better motor skills with support from their families and therapists.

More Cerebral Palsy trials

Quick facts

Study typeInterventional
Ages3 Months to 12 Months
SexAll
Enrollment60 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations2 sites (Aalborg and 1 other locations)
StatusRecruiting
StartedApril 1, 2023
Main results expectedSeptember 30, 2025
Study endsMarch 31, 2028
Registry record updatedJune 1, 2023
Trial IDNCT05883969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are infants aged 3 to 12 months who show early signs of cerebral palsy or have neuroimaging predictive of motor disability.

Probably not a fit

Patients with progressive or neurodegenerative disorders, genetic disorders not associated with cerebral palsy, or other disabilities such as Down Syndrome may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the GO-PLAY intervention program, which is designed to enhance early motor development in infants identified as being at high risk for cerebral palsy. The program is family-centered and involves home-based activities supported by parents and supervised by specialist therapists. Participants will be randomly assigned to receive either the GO-PLAY intervention in addition to standard care or standard care alone. The study aims to recruit approximately 60 infants from multiple sites in Denmark, focusing on those with early signs of cerebral palsy.

Why it matters

Potential benefit: If successful, this intervention could lead to improved motor development outcomes for infants at high risk of cerebral palsy.

How similar studies have gone: Other studies have shown positive outcomes with early intervention programs for infants at risk of cerebral palsy, suggesting that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Infants will be included in the intervention study, if they fulfil at least one of the requirements A or B:

A. any two of the following:

* Neuroimaging predictive of a motor disability including the involvement of one or more of the following structures: sensori-motor cortex, basal ganglia, posterior limb of the internal capsule, pyramidal tracts.
* General Movement Assessment with absent fidgety GMs at fidgety age
* HINE scores \<57 at 3months or \<60 at 6months or \<63 at 9 months or \<66 at 12 months

B. both of the following:

* Unilateral brain injury on neuroimaging (MRI or ultrasound) predictive of CP
* Clinical signs of asymmetry

Exclusion Criteria:

* Infants with progressive or neurodegenerative disorders or genetic disorders not associated with CP
* Infants with other disability diagnoses e.g. Down Syndrome.
* children for whom neither parent is fluent in Danish.

Where it's running

  • Aalborg University Hospital
    Aalborg, Denmark
    Recruiting
  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.